THERAPEUTIC DRUG MONITORING OF INFLIXIMAB AND ADALIMUMAB FOR DETECTION OF PATIENTS AT RISK OF LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE.
Jaime González-López 1
Manuel Barreiro de Acosta 2
José M Giráldez-Montero 3
Rocio Ferreiro Iglesias
María Jesús Lamas-Díaz
Juan Enrique Dominguez-Munoz
1 University Hospital of Santiago de Compostela, Pharmacy, Santiago de Compostela, Spain
2 University Hospital of Santiago de Compostela. Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain, Gastroenterology, Santiago de Compostela, Spain
3 University Hospital of Santiago de Compostela, Pharmacy, Santiag
Conference
UEG Week 2016
Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]